HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
Sample Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
PRODUCTS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1599
The FDA has required new warnings in the labels of gabapentin (Neurontin, and others) and pregabalin (Lyrica, Lyrica CR, and generics) about the risk of life-threatening or fatal respiratory depression in patients with respiratory risk factors. Respiratory risk factors include chronic obstructive pulmonary disease (COPD) and concurrent use of opioids or other CNS depressants. Elderly patients are also at increased...  read more...
More from issue 1599
Coming Soon
Drugs Past Their Expiration Date
Drugs for Atopic Dermatitis
Meloxicam Injection (Anjeso) for Pain
Dapagloflozin (Farxiga) for Heart Failure
Lumateperone (Caplyta) for Schizophrenia
Recommend to Your Library  
Previous Issues
© 2020 The Medical Letter, Inc.